Treatment of infantile haemangioma with captopril

British Journal of Dermatology

Volumn 167, Issue 3, 2012, Pages 619-624

  Tan, S T ^a,b,c,d   Itinteang, T ^a,b,c   Day, D J ^a,b,c   O'Donnell, C ^e   Mathy, J A ^a   Leadbitter, P ^a  

^a HUTT HOSPITAL   (New Zealand)

^b GILLIES MCINDOE RESEARCH INSTITUTE   (New Zealand)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL;

ARTICLE; CAPILLARY HEMANGIOMA; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG DOSE ESCALATION; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFANT; MALE; MASS SCREENING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIDE EFFECT; ULCER;

ANAL CANAL; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; FEMALE; GROIN; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; MALE; SHOULDER; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84865583706     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11016.x     Document Type: Article

References (22)

1. Itinteang T, Withers AHJ, Leadbitter P, et al. Pharmacologic therapies for infantile hemangioma-is there a rational basis? Plast Reconstr Surg 2011; 128: 499-507.
2. Tan ST, Itinteang T, Leadbitter P,. Low dose propranolol for multiple infantile hepatic and cutaneous hemangiomas with deranged liver function. Pediatrics 2011; 127: e772-6.
3. Tan ST, Itinteang T, Leadbitter P,. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg 2010; 64: 292-9.
4. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51. (Pubitemid 351831393)
5. Bigorre M, van Kien AK, Valette H,. Beta-blocking agent for treatment of infantile hemangioma. Plast Reconstr Surg 2009; 123: e195-6.
6. Siegfried EC, Keenan WJ, Al-Jureidini S,. More on propranolol for hemangiomas of infancy. N Engl J Med 2008; 70: 2846-7.
7. Boniface E, Acquafredda A, Milano A, et al. Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol. Pediatr Dermatol 2010; 27: 195-6.
8. Holland KE, Freiden IJ, Frommelt PC, et al. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010; 146: 775-8.
9. Itinteang T, Brasch HD, Tan ST, Day DJ,. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg 2011; 64: 759-65.
10. Itinteang T, Tan ST, Brasch H, Day DJ,. Haemogenic endothelium in infantile haemangioma. J Clin Pathol 2010; 63: 982-6.
11. Itinteang T, Tan ST, Brasch H, Day DJ,. Primitive mesodermal cells with a neural crest phenotype predominate proliferating infantile haemangioma. J Clin Pathol 2010; 63: 771-6.
12. Itinteang T, Tan ST, Brasch HD, et al. Primitive erythropoiesis in infantile haemangioma. Br J Dermatol 2011; 164: 1097-100.
13. Itinteang T, Vishvanath A, Day DJ, Tan ST,. Mesenchymal stem cells in infantile haemangioma. J Clin Pathol 2011; 64: 232-6.
14. Itinteang T, Tan ST, Guthrie S, et al. A placental chorionic villous mesenchymal core cellular origin for infantile haemangioma. J Clin Pathol 2011; 64: 870-4.
15. Artman M, Grayson M, Boerth RC,. Propranolol in children: safety-toxicity. Pediatrics 1982; 70: 30-1. (Pubitemid 12078070)
16. Pavlakovic H, Kietz S, Lauerer P, et al. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics 2010; 6: e1589-93.
17. Cuccaro P, Rapacciuolo A, Vitiello R, et al. Infantile facial haemangioma and subclinical left ventricular dysfunction: the importance of z score in the diagnostic and therapeutic process. J Cardiovasc Med 2010; 11: 692-4.
18. Holmer SR, Hengstenberg C, Mayer B, et al. Marked suppression of renin levels by beta-receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade. J Intern Med 2001; 249: 167-72. (Pubitemid 32202507)
19. Sinaiko AR, Mirkin BL, Hendrick DA, et al. Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease. J Pediatr 1983; 103: 799-805. (Pubitemid 14235453)
20. Scammell AM, Arnold R, Wilkinson JL,. Captopril in treatment of infant heart failure: a preliminary report. Int J Cardiol 1987; 16: 295-301. (Pubitemid 17125604)
21. Shaw NJ, Wilson N, Dickinson DF,. Captopril in heart failure secondary to a left to right shunt. Arch Dis Child 1988; 63: 360-3.
22. Gantenbein MH, Bauersfeld U, Baenziger O, et al. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants. J Perinat Med 2008; 36: 448-52.